UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Annals of the rheumatic diseases, ISSN 0003-4967, 12/2017, Volume 76, Issue 12, pp. 1955 - 1964
autoimmune diseases | polymyositis | dermatomyositis | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Diagnosis, Differential | Biopsy - standards | United States | Europe | Humans | Rheumatology - organization & administration | Probability | Reference Values | Myositis - diagnosis | Consensus | Rheumatology - standards | Societies, Medical - organization & administration | Sensitivity and Specificity | Adult | Muscle, Skeletal - pathology | Child | Myositis - classification | Dictionaries | Dermatology | Pathogenesis | Rheumatic diseases | Clinical trials | Arthritis | Inflammation | Patients | Mimicry | Variables | Neurology | Biopsy | Classification | Rheumatism | Children | Index Medicus | Medicin och hälsovetenskap
Journal Article
Pediatric rheumatology online journal, ISSN 1546-0096, 09/2014, Volume 12, Issue S1, pp. I18 - I18
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 02/2017, Volume 76, Issue 2, pp. 329 - 340
Medicine(all) | Biochemistry, Genetics and Molecular Biology(all) | Immunology | Immunology and Allergy | Rheumatology | Life Sciences & Biomedicine | Science & Technology | Glucocorticoids - therapeutic use | Europe | Humans | Immunosuppressive Agents - therapeutic use | Dermatomyositis - diagnosis | Methotrexate - therapeutic use | Evidence-Based Medicine | Exercise Therapy | Sunscreening Agents - therapeutic use | Dermatomyositis - therapy | Cyclosporine - therapeutic use | Rituximab - therapeutic use | Mycophenolic Acid - therapeutic use | Societies, Medical | Patient Care Team - organization & administration | Prednisolone - therapeutic use | Practice Guidelines as Topic | Index Medicus | Recommendations | Treatment | 1506 | Autoimmune Diseases | Dermatomyositis
Journal Article
Archives of disease in childhood, ISSN 0003-9888, 11/2019, Volume 104, Issue Suppl 4, p. A31
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 04/2018, Volume 57, Issue suppl_3
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 08/2018, Volume 77, Issue 8, pp. 1107 - 1117
Immunology | Rheumatology | Tnf-alpha | methotrexate | Biochemistry, Genetics and Molecular Biology(all) | juvenile idiopathic arthritis | Immunology and Allergy | Life Sciences & Biomedicine | Science & Technology | Severity of Illness Index | Uveitis - diagnosis | Uveitis - etiology | Evidence-Based Medicine - methods | Uveitis - therapy | Glucocorticoids - therapeutic use | Humans | Methotrexate - therapeutic use | Mass Screening - methods | Arthritis, Juvenile - drug therapy | Arthritis, Juvenile - complications | Disease Management | Antirheumatic Agents - therapeutic use | Medical research | Pediatrics | Experts | Disease | Rheumatic diseases | Systematic review | Arthritis | Management | Epidemiology | Patients | Literature reviews | Studies | Validity | Uveitis | Clinical medicine | Children | Diagnosis | Clinical and Epidemiological Research | 1506 | 2311
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 08/2019, Volume 78, Issue 8, pp. 1019 - 1024
Journal Article | DMARDs (biologic) | methotrexate | systemic sclerosis | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Severity of Illness Index | Prednisone - administration & dosage | Prognosis | Drug Administration Schedule | Administration, Oral | Europe | Humans | Male | Scleroderma, Localized - diagnosis | Treatment Outcome | Combined Modality Therapy | Evidence-Based Medicine | Scleroderma, Localized - therapy | Consensus | Dose-Response Relationship, Drug | Phototherapy - methods | Adolescent | Female | Methotrexate - administration & dosage | Disease Management | Drug Therapy, Combination | Child | Practice Guidelines as Topic | Pediatrics | Young adults | Experts | Dermatology | Rheumatic diseases | Management | Light therapy | Patients | Morbidity | Literature reviews | Studies | Validity | Skin | Agreements | Clinical medicine | Scleroderma | Index Medicus | 1506 | 2311 | Recommendation
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 11/2017, Volume 76, Issue 11, pp. 1788 - 1796
Systemic Lupus Erythematosus | Disease Activity | Autoantibodies | Corticosteroids | Treatment | Life Sciences & Biomedicine | Rheumatology | Science & Technology | Evidence-Based Medicine - standards | Young Adult | Europe | Humans | Adolescent | Age of Onset | International Cooperation | Child | Lupus Erythematosus, Systemic - therapy | Lupus Erythematosus, Systemic - diagnosis | Practice Guidelines as Topic | Lupus | Corticoids | Pediatrics | Nephritis | Immunoglobulins | Automation | Nuclear magnetic resonance--NMR | Medical imaging | Experts | Rheumatic diseases | Nervous system | Arthritis | Lupus nephritis | Medical diagnosis | Macrophages | Morbidity | Cell activation | Hydroxychloroquine | Systemic lupus erythematosus | Tomography | Children | Diagnosis | Antiphospholipid syndrome | Index Medicus
Journal Article